Clinuvel Pharmaceuticals (CLVLY)

[FarmaZutical]

Non-executive director acquires 1,3 mio. shares at a price of AUD $10 through a deal with institutional investor Lagoda. Very bullish.

I think it’s more and more likely that Willem Blijdorp and his company B&S International will be
instrumental in distributing Clinuvel’s new cosmetic line and that it will
probably be through tax free retailers in airports; mainly or partly in the Asia Pacific.

Cosmetic giants like Estée Lauder, L’Oréal, Unilever & Procter and Gamble are all very focused
on travel retail, according to this article: http://sc.mp/fJ7SDs

The market is huge and travel retail is exactly what B&S International are experts in.

The article mentions the TFWA international summit in Cannes and how the Tax Free Works Association gathers the
Global travel retail industry in France for this 5 days summit. I’d never heard about TFWA but
apparently Clinuvel attended the 2018 TFWA Asia Pacific conference in Singapore in May: http://clinuvel.com/2007-announcements/ite...gory/776-events

Scenesse isn’t exactly a product for the travel retail market so when Clinuvel attends this
conference it has to be with a different product and scope in mind. Chivere and t’Sumoyle seem
like products that could be a shoe in for this market.

About the billionaire Mr. Blijdorp:

"Mr Blijdorp is the founding member, majority shareholder and a current supervisory Director of B&S International NV, a privately owned Dutch group focused on the wholesale and international trading of luxury and fast moving consumer goods and pharmaceutical products. He managed B&S International for 27 years as CEO and remains actively involved in the company’s expansion strategy, helping it to become one of the largest trading houses globally with a compounded annual growth rate of 10% for the past decade. Being recognised for his expertise in merger and acquisitions and leadership, in 2014 Mr Blijdorp was awarded the Ernst & Young Entrepreneur of the Year in the Netherlands."